Summary.-Double stranded RNA (dsRNA) whether isolated from a fungal virus or prepared synthetically (i.e., Poly I Poly C) and endotoxin were found to exert very similar effects on syngeneic murine lymphomata and fibrosarcomata. They cause complete regressions of some established subcutaneous (s.c.) or intradermal (i.d.) tumours but not of intraperitoneal (i.p.) tumours when administered either systemically or directly into the tumour. To achieve this effect the tumours must be fully established and the best results were obtained when treatment was started 7 days after transplant. If treatment is started within the first 3 days following the transplantation of the tumour then only a slight inhibition of growth rate was observed. These agents can also act prophylactically and protect mice against a subsequent challenge but only if this is given i.p. and not if given s.c. or i.d. The prophylactic action is explained by the action of dsRNA and endotoxin on peritoneal macrophages which cause them to become cytotoxic to tumour cells (i.e., to become activated).
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The therapeutic effect of systemically administered endotoxin and dsRNA on established tumours is not the result of a direct action on the tumour cells themselves but is a complex process requiring the co-operation of several host factors. Haemorrhagic necrosis involving coagulation is essential (i.e., heparinization reduces the regression of tumours) but is not itself sufficient. Immunosuppression by whole body irradiation or by antilymphocyte serum also interferes with the antitumour action of dsRNA and endotoxin in spite of the fact that haemorrhagic necrosis still occurs. Also, the magnitude of the antitumour action correlated in a series of different tumours with their antigenicity. The observed tumour regressions are probably brought about by (1) vascular damage in the tumour which permits immune defence mechanisms of the host to gain access to the tumour and (2) activation of macrophages present within the tumour. The relative contribution of these two mechanisms may depend on the nature of the tumour and the route of administration of the active agents.
Dibenyline, which protects against the lethal action of endotoxin by preventing the action of the catecholamines on the a-adrenergic receptors, makes it possible to increase the effectiveness of endotoxin in tumours by allowing a large dose to be given. Lipid A, a derivative of endotoxin which does not contain polysaccharide, has similar antitumour action to dsRNA and endotoxin. Some common features of the chemical structure of lipid A and dsRNA are discussed.
Over a hundred years ago (Busch (Coley's toxin) , which contained endotoxins 1866), a Viennese physician noted that amongst many other components, and regressions of some malignant tumours achieved some very striking results (cf. appeared to coincide with the occurrence review by Nauts, Fowler and Bogatko, of erysipelas. Coley, having made a 1953). The subject of the antitumour similar observation, deliberately treated action of endotoxins has attracted much patients with bacterial culture fluids attention during the whole of this century, but from aii experimental standpoint, the key publication is that of Andervont (1936) , in which he showed that large pritnary chemically-induced epitheliomata of mice regressed completely following systemnic treatment with endotoxin and that these striking effects were associated with a haemG-irrhagic reaction and resultant damage of the tumour vasculature. Using primary as well as transplanted tumours in syngeneic systems, Andervont found that endotoxin was effective only after tumours had become fully established and was inactive when given immediately after a transplant. Double-stranded RNA (dsRNA) both of natural origin (e.g., when isolated from fungal viruses) and when prepared synthetically (i.e., Poly I Poly C) mimics many of the biological actions of endotoxin, such as toxicity and interferon induction. Both types of dsRNA have also been. found to slow the growth of a variety of transplanted mrouse tumours and leukaemias (Levy, Law anid Rabson, 1969; Pilch anid Planterose, 1971 ). Typical endotoxin-type i,ntitumour action (i.e., an effect which predominantly affected established tumour) had been recognized for dsRNA by Pilch and Plaiterose (1971) but in most of the other studies this was not noted because in general the dsRNA was administered soon after transplantation of the tumours.
Our interest in the antitumour activities of endotoxin and of dsRNA derived from the observation that after exposure to either of these substances int vivo or in vitro, peritoneal macrophages acquired the capacity to inhibit the growth of lymphoma and sarcoma cells (Alexander and Evans, 1971) . Neither endotoxin nor dsRNA, at the concentrations used to treat macrophages, have a direct effect on the growth of tumour cells in vitro. The term " activated " has been used to describe inacrophages that have acquired the capacity to inhibit in vitro the growth of tumour cells that are in direct contact with them and they need to be distinguished froml .armed" macrophages which kill tumour cells in an immunologically specific way. Since the growth inhibitory effect of activated macrophages is confined to tumour cells (Hibbs, Lambert and Remm.ington, 1972) Levy (1970) has attributed the effect of dsRNA as an antitumour agent to this property. While it has been clearly shown that much more potent stimulants of the immune system than dsRNA, s-uch as mycobacteria (e.g., BCG) and (1orynebacteriunm parvum, render rodents more resistant to a subsequent challenge with tumour cells (Halpern et al., 1959 (Halpern et al., , 1966 Old et al., 1961) , such agents have only a minor therapeutic effect when given after the tumour has been injected (Mathe, Pouillant and Rapeyraque, 1969; Parr, 1972 Tumours.-Two tumours, a lymphoma L5178Y and a fibrosarcoma FS6, were used for the majority of the experiments. Brief details of these and the other tumour lines used are given in Table I . The lymphomata were maintained in the ascitic form by serial weekly passage of washed, counted tumour cells into the strain of origin. Transplant of the fibrosarcomata was fortnightly by means of trocar fragments. At 4-5 monthly intervals the tumours were re-established from stock tumour cell lines maintained in liquid nitrogen. Single cell suspensions were prepared from the fibrosarcomata by enzymic digestion of minced tissues with TC.199 medium containing 0.13% trypsin, 0.13% collagenase and 0 002% DNAase for 15 min at room temperature.
Subcutaneous or intradermal challenges were made into the right flank of the animal. Growth of tumour was followed by bi-weekly measurement of two diameters by means of calipers.
dsRNA, which was kindly supplied by Beecham's Research Laboratories, was from a fungal virus obtained from a penicillin mould (Planterose et al., 1970 Freiburg, Germany) and are described by Galanos et al. (1971) : A glycolipid from Salmonella minnesota (R595) which was dissolved in water by heating in a water bath for 2 minutes. Lipid A from S. minnesota (R345) which had been rendered soluble in water by 3 methods: with the aid of pyridine, by treatment with NaOH (1 hour at 56TC) and by complexing with bovine serum albumin (BSA) in a 12 : 1 BSA/Lipid A ratio. Isotonic solutions for injection (i.p.) were prepared by addition of concentrated saline to solutions of Lipid A in water. Dibenyline was obtained from Smith, Kline and French laboratories. Mice received 100 jug/animal in volumes of 1 ml injected i.p. 2 hours before administration of endotoxin. Mice received 3 injections (s.c.) each of 100 iu heparin per 24 hours. Fine needles (gauge 30) were used to minimize the numbers of deaths from bleeding.
Antilymphocyte serum was prepared by sensitizing rabbits with mouse thymocytes according to the method described by Sutthiwan et al. (1969) . Eight injections of 0-1 ml of ALS were given i.p. on alternate days, beginning 2 days after tumour transplant. 1961 1968 1968 1968 1967 1969 1970 1970 1970 Whole body x-irradiation of 400 rad at the rate of 83 (Table  III) . This dose, however, could not be tolerated under all conditions since environmental factors affect toxicity. Both the toxicity and antitumour activity of endotoxin are very dependent on the temperature at which the animals are maintained and no attempt was made to establish a dose-response curve. Under normal conditions in the animal house (i.e., 25°c) 10 jug of endotoxin regularly caused tumour regression. Increasing the dose to 15, 20 and 25 ,ug did not improve the antitumoir effect and the latter made the mice obviously sick. Consequently a dose of 10 jag/mouse was used throughout.
However, under conditions of above average environmental temperature (i.e., in the range 26-29°C) 1 jag endotoxin per mouse was sufficient to induce permanent tumour regression in 4/5 animals.
Attempts to give repeated doses of 10 jag of endotoxin resulted in the death of 50% of the animals.
Fibrosarcomata.-The initial experiments were made on mice carrying trocar fragments of tumour placed in the flank. Table I. t Different sample of dsRNA.
In an experiment similar to the one described for the lymphoma, dsRNA treatment (100 ,ug twice weekly) was started in different groups of mice 1, 10, 16 and 20 days after transplant of FSI fibrosarcoma (Fig. 3) Injection of dsRNA directly into the tumour mass was more effective than intraperitoneal inoculation. Table VII shows that 100 ,ug of dsRNA injected into L5178Y lymphoma induced greater inhibition of tumour growth than 5 similar doses given i.p. This response was not increased by repeated intralesional inoculation. On the other hand, for the fibrosarcomata repeated injections of dsRNA into the tumour were necessary to achieve permanent regression. The toxicity of dsRNA given intralesionally was less than when given by the intraperitoneal route. The extent of tumour necrosis and the incidence of tumour regression following end(lotoxin treatment were greatest in the more antigenic tumours, i.e., L5178Y and FS6, and much less marked in those lymphomata and fibrosarcomata which by standard transplantation tests would be considered less antigenic (see Table VIII ). On the other hand, there were occasionally well defined areas of superficial necrosis in those tumours, e.g., TLX9, FS9 which failed to respond. In these latter tumours there was no accompanying softening of the surrounding tumour tissue which continued to grow at the original rate.
B. Activity of structurally related macromolecules The marked similarities of the antittumour activities of endotoxin and dsRNA (e.g., the importance of timing, the failure of established i.p. tumours to respond and the appearance of the tumour after treatment) raise the possibility that the activity of dsRNA may be due to contamination with endotoxin. However, this was excluded when it was found that samples of dsRNA which had previously been treated with RNAase lost their antitumour activity against i.d. L5178Y lymphoma (see Table IX ).
In the tumrour systems studied by us the synthetically prepared Poly I Poly C showed the same type of activity as the (IsRNA from the fungal virus. The data (see Table IX 3/9 * Defined in Table II Alexander and Evans (1970) had shown that both lymphoma and sarcoma cells grow normally tn vitro in the presence of 50 ,tg of dsRNA or endotoxin. However, at very much lower concentrations these macromolecules " activate " macrophages and render them cytotoxic to lymphoma and sarcoma cells. An apparent cytotoxic action of these agents can be sometimes observed in cultures of sarcoma cells established from cells obtained directly from a sarcoma. This effect, however, is mediated by macrophages. Sarcomata in mice and rats contain macrophages and sometimes up to 40% of the cells derived by enzyme digestion of a sarcoma are macrophages (Evans, 1972 Table X ).
2. Vascular effects of endotoxin Shwartzman (1937) and Andervont (1936) attributed the effect of endotoxin on established tumours to a haemorrhagic reaction. The changes produced by endotoxin in tumours are in many respects similar to a local Shwartzman reaction. In the latter, necrosis is produced by systemic administration of endotoxin fol- lowing an initial primary dose given locally. The tumour vasculature without prior exposure to endotoxin seems to respond to endotoxin like the blood vessels in skin after initial sensitization. Since the local Shwartzman reaction can be inhibited by administration of heparin (Good and Thomas, 1953) , the effect of full heparinization on the antitumour action of endotoxin was studied with both L5178Y lymphoma and the FS6 sarcoma. Twenty mice were heparinized on Day 7 after inoculation i.d. of 106 L5178Y cells. Endotoxin (10 ,tg per mouse) was injected into 10 of these animals 4 hours after the first dose of heparin. Injections ofheparin (3 per 24 hours) were continued for a total period of 4 days. The haemorrhagic necrotic action was rather slower to appear in the tumours of the heparinized animals but the usual scabs had formed over the tumours before the period of heparinization was over. Some tumour regression was observed in the heparinized mice but the effect was greatly reduced when compared with that seen in normal mice (Table XI) . In a similar experiment, animals carrying FS6 fibrosarcomata were heparinized and then treated with endotoxin. Tumour necrosis was reduced and the inhibition of tumour growth was only slight in the heparinized group (Table XI) . (Table XII) . In a further experiment where the dose of dibenyline was increased from 100 ,tg to 500 ,ag/mouse, the signs of haemorrhagic necrosis were slower to appear in the tumours of the dibenyline-endotoxin group of animals, but tumour regression still occurred. However, dibenyline protected powerfully against the toxic effects of endotoxin and made it possible to use much higher doses of the latter. The possibility that higher doses of endotoxin in mice protected by dibenyline may cause tumours to regress which had failed to respond to 10 jtg of endotoxin was investigated with the fibrosarcoma FS9. CBA mice carry-9-day-old FS9 fibrosarcomata were injected Antitumour Action of Endotoxin with 100 jug of endotoxin 2 hours after i.p injection of 100 ,tg of dibenyline. Table  XII shows that this tumour responded to the higher dose of endotoxin which had been made possible by protection with dibenyline. We conclude that the biological effects of endotoxin, which are protected against by dibenyline, do not play a significant role in causing tumour regression and that in combination with dibenyline endotoxin can be more effectively employed. Dibenyline, however, failed to protect against the toxic effects of dsRNA and did not make it possible to use a higher dose of this compound. temporary regressions and a slowing of growth. In animals that had been irradiated dsRNA was totally without effect. The influence of whole body irradiation on the action of endotoxin against the flbrosarcoma was not so dramatic but there was a reduction of response. This series of experiments does not by itself prove that an intact immutne mechanism is needed for the antitumour action of dsRNA and endotoxin to be manifested, since whole body irradiation causes widespread pathological changes and in particular induces leucocytopenia. However, two other treatments which are immunosuppressive, namely administration of ALS and of cortisone, botlh reduce the antitumour action of endotoxin (Table XIV) . It is difficuilt to envisage an effect other than immunosuppression which is shared by whole body irradiation and treatment with ALS or cortisone, and while the hypothesis that an intact immune system is needed for endotoxin and dsRNA to cause regression of established tumours has not been unambiguously proven by these experiments, it is extremely likely. It is of interest that haemorrhagic necrosis still occurred in tumours of endotoxintreated mice that had been exposed to whole body irradiation. Intradermal L5 1 78Y tumours growing in mice subjected to 400 rad 24 hours before tumour transplant, were treated with 1 lig, 5 /,g or 10 ,ug per mouse of endotoxin and the degree of haemorrhagic necrosis occurring in the tumours assessed in a " blind " study by two individuals. It was found that although haemorrhagic necrosis did not occur as quickly in the irradiated mice and did not, except in the group given 10 jug of endotoxin, reach quite the same intensity, it did still occur whereas the antitumour activity of endotoxin was completely absent in the irradiated mice (Table XIII) .
DISCUSSION
With regard to all of the toxic manifestations, including pyrexia, shock syndromes, enhancement of toxicity by lead acetate and temperature elevation, effect on complement and blood clotting systems and intravascular coagulation, as well as the activation of macrophages, dsRNA (both of viral origin and synthetic Poly I Poly C) cannot be distinguished qualitatively from endotoxin and, as far as the limited data warrant, from lipid A.
In this paper we have demonstrated that this similarity in activities also applies to the antitumour actions. These substances appear to have two quite distinct effects on tumour growth (1) prophylactic when given several days before challenge and (2) therapeutic when given several days after tumour implantation. With That an immune reaction of the host directed against the tumour contributes to the tumour regression induced by dsRNA and endotoxin is indicated by the fact that only strongly antigenic tumours respond to these treatments. Moreover, in animals that have been deliberately immunosuppressed by ALS or whole body irradiation, tumour regressions are not induced. Admittedly these pre-treatments also affect the blood clotting system, but since haemorrhagic necrosis still occurs it seems more likely that it is immunosuppression, and not some other pathology induced by both x-rays and ALS, which counteracts the antitumour activity of dsRNA and endotoxin. The failure of dibenyline to block the antitumour action indicates that this effect is not mediated via the action of endotoxin on the adrenergic nervous system.
The apparent need for both haemorrhagic necrosis and an active immune response suggests that the effect of dsRNA and of endotoxin on tumours is due to a breakdown of the vascular structure which allows the various immunological effector mechanisms of the host to gain access to the tumour. Physical inaccessibility of cells in a solid tumour is one reason for the relative immunotherapeutic ineffectiveness of antisera and the same may well apply to some of the cellmediated components of the immune response. Vascular damage alone can only cause a temporary slowing of tumour growth, but when this occurs in a host which is reacting to an antigenic tumour, then the combined response may result in the regressions that are observed.
In addition to haemorrhagic necrosis and host immunity, activation of macrophages may be another and parallel mechanism in the antitumour reaction. Evans (1972) Fischer et al. (1972) who utilized a fibrosarcoma and a polyoma for their work. Secondly, the effect of dsRNA injected directly into the tumour was not increased in the case of the lymphoma by repeated treatment whereas the opposite was true of FS6 fibrosarcoma (Table VI) . These differences might be explained in terms of the varying contributions of the two processes capable of causing tumour regression, for example (1) vascular damage with the ensuing release of immune factors and (2) macrophage activation. The first mechanism would be sensitive to immunosuppression whereas there is evidence that macrophage activation would not. In vitro experiments by den Otter (unpublished) show that macrophages that have been subjected to x-irradiation can still be activated by addition of dsRNA or endotoxin. The low macrophage content of intradermal L5178Y lymphomata (personal observation) compared to the 4000 present in FS6 fibrosarcomata (Evans, 1972) The finding that the polysaccharidefree endotoxin derivative lipid A has the structure shown in Fig. 5 (Gmeiner et al., 1969) , allows some speculation concerning a possible molecular basis for the similarity in action of dsRNA and endotoxin. It is not inconceivable that both may bind to a common receptor on cells which relies for its specificity on a combination of recurring phosphate groups, present in both macromolecules, and of a hydroxyl group provided by the myristic acid in lipid A and by ribose in dsRNA. We wish to thank Dr R. L. 
